QNTM
Quantum BioPharma Ltd.
NASDAQ: QNTM · HEALTHCARE · BIOTECHNOLOGY
$5.73
+1.42% today
Updated 2026-04-30
Market cap
$31.77M
P/E ratio
—
P/S ratio
91.86x
EPS (TTM)
$-8.20
Dividend yield
—
52W range
$2 – $38
Volume
0.5M
Quantum BioPharma Ltd. (QNTM) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $2160.00 | $7137.00 | $10.88M | $38.75M | $43.22M | $41.97M | $62.96M | $38.41M | $17.47M | $17.12M |
| Cash & equivalents | — | $7137.00 | $3.77M | $15.52M | $5.97M | $17.52M | $35.26M | $16.98M | $2.76M | $6.00M |
| Current assets | $2160.00 | $7137.00 | $4.28M | $16.57M | $8.56M | $26.87M | $45.93M | $17.85M | $11.09M | $12.05M |
| Total liabilities | $60530.00 | $61434.00 | $1.01M | $1.28M | $6.94M | $5.66M | $8.83M | $7.87M | $4.57M | $6.68M |
| Current liabilities | $60530.00 | $61434.00 | $1.01M | $1.28M | $6.83M | $5.58M | $8.70M | $7.83M | $4.57M | $6.68M |
| Long-term debt | — | — | — | — | — | — | — | — | — | — |
| Shareholder equity | $-58370.00 | $-54297.00 | $9.87M | $37.47M | $36.28M | $36.31M | $54.13M | $30.54M | $13.24M | $11.48M |
| Retained earnings | $-1.26M | $-1.30M | $-3.35M | $-19.46M | $-59.07M | $-90.87M | $-126.15M | $-144.16M | $-157.91M | $-172.11M |
| Accounts receivable | $2160.00 | — | $234201.00 | $727581.00 | $1.56M | $161342.00 | $500964.00 | $374377.00 | $7.42M | $3.81M |
| Inventory | — | — | — | — | $709373.00 | $0.00 | — | — | $0.00 | $117242.00 |
| Goodwill | — | — | — | — | — | — | — | — | — | — |